Earnings Preview: Amicus Therapeutics, ANSYS, and Etsy Take Center Stage
- February 16th, 2025
- 802 views
On Wednesday, February 19, a series of companies are gearing up to release their financial results, including:
Amicus Therapeutics, Inc. (Nasdaq: FOLD), a biotechnology company specializing in rare and orphan diseases, will report its full-year 2024 financial results before the market opens. Market consensus points to expected earnings per share (EPS) of $0.09 on revenue totaling $147.87 million. On Friday, $FOLD closed at $9.77, up $0.13 (+1.35%).
ANSYS, Inc. (Nasdaq: ANSS), a leader in engineering simulation software, will release its fourth-quarter and full-year 2024 earnings after the market closes. The consensus estimate is EPS of $3.86, accompanied by revenue reaching $864.46 million. $ANSS closed at $338.93 on Friday,, down $0.24 (-0.07%).
Etsy, Inc. (Nasdaq: ETSY), the e-commerce platform known for handmade and vintage goods, will announce its fourth-quarter and year-end 2024 financial results before the market opens. Analysts forecast EPS of $0.94 on revenue of $861.37 million. On Friday, $ETSY closed at $57.20, reflecting an increase of $1.88 (+3.40%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP National Football Conference Names David Dalton Head Coach of Salt Lake Yeti
February 06th, 2026FDA Takes New Approach to "No Artificial Colors" Claims
February 06th, 2026NJCP National Football Conference Announces Micah Deckart as Head Coach of the Idaho Outlaws
February 05th, 2026
Member Login